Rx-360 announces Mark Paxton as new CEO
Rx-360’s first CEO will lead the consortium to its next phase of growth.
Rx-360 has appointed Mark S. Paxton to the position of CEO of the international pharmaceutical supply chain consortium. This appointment follows the successful growth of the organization since its foundation in 2009 in the aftermath of the adulterated heparin tragedy. Mark will provide leadership to a vibrant organization of 300 volunteers from over 100 institutions that are organized in 17 working groups with activities in the US, Europe, China and India.
Rx-360’s first CEO will lead the consortium and its membership in executing the Board’s Strategic Plan, expanding its membership and creating global awareness of Rx-360’s central mission: To protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain.
“I am delighted to welcome Mark to Rx-360. We have in Mark the leader that will take the consortium to its next phase of growth so that we may harness the passion of all those of us in the Industry that put the patient ahead of everything else,” says Guy Villax, Rx-360 Chair.
Mark comes to Rx-360 from the FDA where he led an international Strategic Program focused on medical product quality and supply chain security under Asia-Pacific Economic Cooperation (APEC), a multi-lateral forum of governments to promote sustainable economic growth within the Asia-Pacific region.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance